4S

Acousort ABFRA Acousort Stock Report

Last reporting period 30 Jun, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.028

Micro

Exchange

XFRA - Deutsche Boerse AG

4SA.F Stock Analysis

4S

Uncovered

Acousort AB is uncovered by Eyestock quantitative analysis.

Market cap $B

0.028

Dividend yield

Shares outstanding

13.202 B

AcouSort AB engages in the provision of biotechnology. The company is headquartered in Lund, Skane. The company went IPO on 2017-01-09. The firm develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.

View Section: Eyestock Rating